Product Images Dexamethasone Sodium Phosphate

This is a description of a medication called Dexamethasone Sodium Phosphate, that comes in an injection form with a 20mg per ml concentration. It's indicated for intra-articular, soft tissue or intraleisional use. It's recommended to protect it from light, heat, and freezing. It's also sterile and should be kept out of children's reach. The medication is packaged and controlled, and its storage recommended in a controlled room with temperatures ranging between 69F and 77F. There's a lot number provided with a reference to the manufacturer's insert. The prescribing information is not available.*

This text provides dosing information for several drugs administered via intravenous injection for the treatment of shock in varying doses depending on the drug, ranging from 1 mg/kg to 3 mg/kg, and with repeated injections every 2 to 6 hours in some cases.*

This text provides a dosing guide for administering Dexamethasone in different sites of injection depending on the affected area. The dosage is given in milligrams (mg) and varies based on the size of the joint or affected area. It includes instructions for injecting into large joints such as the knee, small joints like the interphalangeal or temporomandibular joint, bursae, tendon sheaths, soft tissue infiltration, and ganglia.*

This text describes different NDC numbers for a medication. It provides information about the fill volume and pack size of the medication in different vial sizes. The first NDC number is for a single-dose vial with a fill volume of 1 mL and a pack size of 25. The second NDC number is for a multi-dose vial with a fill volume of 5 mL and a pack size of 25. The third NDC number appears to have a typo in the word "Mutti-Dose" but suggests a fill volume of 30 mL and a pack size of 25.*

This is a product or medication with NDC number 67457-420-10. It comes in a pack size of 10 multi-dose vials, with each vial containing 10 mL of the product.*

This is a list of references regarding shock and its treatment, including endotoxin shock in pregnancy and abortion, high-output low-resistance gram-negative septic shock in man, clinical observations in shock and management, endotoxin shock in the geriatric patient, and corticosteroid effect on biochemical parameters of human oligemic shock.*